Institutional investors purchased a net $3.3 million shares of TROV during the quarter ended September 2016, and now own 19.27% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MILLENNIUM MANAGEMENT LLC Bought 276.1 Thousand shares of Trovagene Inc
BLACKROCK FUND ADVISORS Bought 120.7 Thousand shares of Trovagene Inc
HIGHTOWER ADVISORS LLC Bought 80.5 Thousand shares of Trovagene Inc